{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:01:22Z","timestamp":1794452482893,"version":"4.9.1"},"publisher-location":"Boston, MA","reference-count":16,"publisher":"Springer US","isbn-type":[{"value":"9781489926401","type":"print"},{"value":"9781489926388","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1991]]},"DOI":"10.1007\/978-1-4899-2638-8_18","type":"book-chapter","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:58:38Z","timestamp":1373936318000},"page":"83-86","source":"Crossref","is-referenced-by-count":3,"title":["6-Mercaptopurine Metabolism in Two Leukemic Cell Lines"],"prefix":"10.1007","author":[{"given":"E. H.","family":"Stet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"De Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. P. G.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P. M.","family":"B\u00f6kkerink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M. F.","family":"Trijbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"18_CR1","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1200\/JCO.1989.7.12.1816","volume":"7","author":"L Lennard","year":"1989","unstructured":"L. Lennard, J.S. Lilleyman, Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblasic leukemia, J. Clin. Oncol. 7:1816 (1989).","journal-title":"J. Clin. Oncol."},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/clpt.1986.178","volume":"40","author":"L Lennard","year":"1986","unstructured":"L. Lennard, D. Keen, J.S. Lilleyman, Oral 6-mercaptopurine in childhood leukemia: parent drug pharmacokinetics and active metabolite concentrations, Clin. Pharmacol. Ther. 40:287 (1986).","journal-title":"Clin. Pharmacol. Ther."},{"key":"18_CR3","first-page":"124","volume":"76","author":"M Uchida","year":"1985","unstructured":"M. Uchida, T. Nakamura, H. Uchino, Conversion of 6-mercaptopurine to 6-thioguanylic acid in L1210 cells and human leukemia cells, Jpn.J. Cancer Res. (GANN) 76:124 (1985).","journal-title":"Jpn.J. Cancer Res. (GANN)"},{"key":"18_CR4","unstructured":"J.P.M. B\u00f6kkerink, F.J. Damen, T.W. Hulscher, M.A.H. Bakker, J. A van Baal, R.A. De Abreu, 6-mercaptopurine cytotoxicity and biochemical pharmacology in human malignant lymphoblasts of different lineages, submitted"},{"key":"18_CR5","first-page":"2872","volume":"35","author":"JA Nelson","year":"1975","unstructured":"J.A. Nelson, J.W. Carpenter, L.M. Rose, D.J. Adamson, Mechanisms of action of 6-thioguanine, 6-mercaptopurine and 8-azaguanine, Cancer Res. 35:2872 (1975).","journal-title":"Cancer Res."},{"key":"18_CR6","first-page":"3852","volume":"43","author":"J Maybaum","year":"1983","unstructured":"J. Maybaum, H.G. Mandel, Unilateral chromatid damage: a new basis for 6-thioguanine cytotoxicity, Cancer Res. 43:3852 (1983).","journal-title":"Cancer Res."},{"key":"18_CR7","first-page":"3665","volume":"44","author":"NT Cristie","year":"1984","unstructured":"N.T. Cristie, S. Drake, R.E. Meyn, J.A Nelson, 6-Thioguanine-induced DNA-damage as determinant of cytotoxicity in cultured hamster ovary cells, Cancer Res. 44:3665 (1984).","journal-title":"Cancer Res."},{"key":"18_CR8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1182\/blood.V75.3.570.570","volume":"75","author":"FR Collart","year":"1990","unstructured":"F.R. Collart, E. Huberman, Expression of IMP dehydrogenase in differentiating HL60 cells, Blood 75:570 (1990).","journal-title":"Blood"},{"key":"18_CR9","first-page":"152","volume":"31","author":"LL Bennet","year":"1971","unstructured":"L.L. Bennet, P.W. Allan, Formation and significance of 6-methylthiopurine ribonucleotide as a metabolite of 6-mercaptopurine, Cancer Res. 31:152 (1971).","journal-title":"Cancer Res."},{"key":"18_CR10","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0021-9258(18)81262-5","volume":"238","author":"CN Remy","year":"1963","unstructured":"C.N. Remy, Metabolism of thiopyrimidines and thiopurines; S-methylation with S-adenosyl methionine transmethylase and catabolism in mammalian tissue, J. Biol. Chem. 238:1078 (1963).","journal-title":"J. Biol. Chem."},{"key":"18_CR11","unstructured":"A R.P. Paterson, D.M. Tidd, 6-thiopurines, in: \u201cAntineoplastic and immunosuppressive agents II\u201d, A.C. Sartorelli, ed, Plenum Berlin, Heidelberg, New York (1975)."},{"key":"18_CR12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0378-4347(00)80354-0","volume":"227","author":"RA Abreu De","year":"1982","unstructured":"R.A. De Abreu, J.M. van Baal, J.AJ.M. Bakkeren, C.H.M.M. de Bruyn, E.D.A.M. Schretlen, High performance liquid Chromatographic assay for identification and quantitation of nucleotides in lymphocytes and malignant lymphoblasts, J. Chromatogr. 227:45 (1982).","journal-title":"J. Chromatogr."},{"key":"18_CR13","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/0006-2952(88)90358-9","volume":"37","author":"JPM B\u00f6kkerink","year":"1988","unstructured":"J.P.M. B\u00f6kkerink, M.A.H. Bakker, T.W. Hulscher, R.A De Abreu, E.D.A M. Schretlen, Purine de novo synthesis as the basis of synergism of methotrexate and 6-mercaptopurine in human malignant lymphoblasts of different lineages, Biochem. Pharmacol. 37:2321 (1988).","journal-title":"Biochem. Pharmacol."},{"key":"18_CR14","first-page":"5512","volume":"45","author":"HJ Lee","year":"1985","unstructured":"H.J. Lee, K. Pawlak, B.T. Nguyen, R.K. Robbins, W. Sad\u00e9e, Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture, Cancer Res. 45:5512 (1985).","journal-title":"Cancer Res."},{"key":"18_CR15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1182\/blood.V75.3.583.583","volume":"75","author":"SM Kharbanda","year":"1990","unstructured":"S.M. Kharbanda, M.L. Sherman, D.W. Kufe, Effects of tiazofurin on guanine nucleotide binding regulatory proteins in HL60 cells, Blood 75:583 (1990).","journal-title":"Blood"},{"key":"18_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0898-6568(90)90073-J","volume":"2","author":"MT Rizzo","year":"1990","unstructured":"M.T. Rizzo, G.T. Tricot, R. Hoffman, H.N. Nayaram, G. Weber, J.G.N. Garcia, D. English, IMPDH inhibitors. Probes for investigation of the functions of guanine binding proteis in intact cells, Cell. Signal. 2:509 (1990).","journal-title":"Cell. Signal."}],"container-title":["Advances in Experimental Medicine and Biology","Purine and Pyrimidine Metabolism in Man VII"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4899-2638-8_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,28]],"date-time":"2022-02-28T23:13:50Z","timestamp":1646090030000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4899-2638-8_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991]]},"ISBN":["9781489926401","9781489926388"],"references-count":16,"URL":"https:\/\/doi.org\/10.1007\/978-1-4899-2638-8_18","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4899-2638-8","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[1991]]}}}